New Horizons – Using Real World Evidence to Impact Future Clinical Trials
Pete Knox of The Life Raft Group presented Using Real World Evidence to Impact Future Clinical Trials and Improve Patient Survival: A Focus on Placebos at New Horizons 2021.
New Horizons – The Story of How GIST Treatments Began
Dr. George Demetri of the Dana-Farber Cancer Institute presented “In the Beginning…The Story of How GIST Treatments Began”.
New Horizons – Long-term GIST Survivor Story
Chuck Korte presented his story as Long-term GIST Survivor at New Horizons 2021.
New Horizons – Clinical Trials: From 2000 to 2021
Dr. David Josephy and Jim Hughes presented "Clinical Trials 2000-2021" at New Horizons 2021.
New Horizons – Lessons Learned from the GIST & CML Community
Giora Sharf and Norman Scherzer presented "Lessons Learned from the GIST & CML Community" at New Horizons 2021.
New Horizons – Current GIST Treatment Options
Dr. Jonathan Noujaim and Dr. Yoon-Koo Kang presented an update to "Current GIST Treatments" at New Horizons 2021.
It’s Time: The Life Raft Group Biomarker Testing Campaign – It’s Time for Action
Understanding the role of mutations and biomarker testing is one of most important things patients must learn. Uncovering the driving force behind each individual’s tumors is not just important, it is critical. This video shows the action steps of our It's Time campaign.
Gastrointestinal Stromal Tumor (GIST) in India
This video contains information about Gastrointestinal Stromal Tumor (GIST) presented by Dr. Sameer Rastogi, All India Institute of Medical Sciences, New Delhi, India.
Avapritinib in PDGFRA D842V GIST
This video deals with the mechanism of avapritinib in GIST, current outcomes and challenges with PDGFRA D842V mutated GIST presented by Dr. Sameer Rastogi, All India Institute of Medical Sciences, New Delhi, India..
It’s Time: The Life Raft Group Biomarker Testing Campaign – Terminology
Understanding the role of mutations and biomarker testing is one of most important things patients must learn. Uncovering the driving force behind each individual’s tumors is not just important, it is critical. This video talks about why it's important and about terminology when talking about mutations.